Koseikai Takeda Hospital

Kyoto 600-8558

0 studies enrolling now · 4 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Alzheimer Disease, Alzheimers Disease, High-risk Transient Ischemic Attack, Ischemic Stroke; Ischemic Attack, Transient, Prevention of Ischemic Stroke

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling